QIAGEN latest solutions in cancer research and diagnostics

Identify and quantify rare sequences or mutations, fusion genes and CNVs, monitoring cancer progression and treatment effects, and detecting relapses early with high sensitivity.

Automate nucleic acid extractions for up to 24 samples simultaneously using prefilled cartridge-based workflows and preprogrammed protocols for various sample types – FFPE, liquid biopsy, cells, tissue, whole blood.

Analyze key mutations in BRAF and EGFR genes with exceptional sensitivity and specificity from different sample types. Streamline pre-screening processes and long-term monitoring in your cancer research while reducing time and cost.

Learn more at AACR 2024

Characterize T-cell receptors (TCRs) repertoire in humans or mice using NGS, covering TCR receptor genes (TCR-alpha, TCR-beta, TCR-gamma, TCR-delta).

Accelerate your cancer genomic profiling with LightSpeed technology for accurate, high-speed, and low-cost data analysis and visualization. Analyze data in the cloud, server or a standard computer – no coding required.

Detect ultra-rare variants from cfDNA, including circulating-tumor DNA, to 0.1% variant allele frequency with an ultralow error rate and minimal hands-on time

Integrate partitioning, processing, PCR, and analysis into a single touchpoint, benchtop dPCR system for your diagnostics lab.

*The QIAcuityDx IVD medical device is under development and has not yet been placed on the market.